Clinical Report: Supporting Innovation and Advocacy in Pathology

Overview

The ASCP Pathologist Council is addressing workforce challenges and enhancing educational resources for pathologists through initiatives such as a survey on burnout and a survival guide for early-career pathologists.

Background

Workforce attrition and staffing shortages are significant challenges in pathology. The ASCP Pathologist Council aims to support pathologists through advocacy, education, and resources tailored to their needs.

Data Highlights

No numerical or trial data available in the source material.

Key Findings

• The ASCP Pathologist Council connects ASCP with pathologist members to shape priorities.
• A survey is being developed to assess burnout and job satisfaction among pathologists.
• Dynamic educational content is being created for trainees and practicing pathologists using social media.
• A self-paced survival guide for early-career pathologists is being assembled.
• Resources will cover topics such as financial literacy and quality improvement.

Clinical Implications

The ASCP Pathologist Council's initiatives aim to address workforce challenges and improve educational resources for pathologists.

Conclusion

The ASCP Pathologist Council's initiatives focus on addressing challenges in the pathology profession and enhancing educational opportunities.

Related Resources & Content

1. the pathologist — Speaking for the Community, 2026 -- Advocacy in Pathology
2. the pathologist — Going Digital in Community Pathology, 2026 -- Digital Pathology Insights
3. the pathologist — Pathology Clinics: Bringing the Lab out of the Basement, 2026 -- Innovative Practice Models
4. Interpretive Diagnostic Error Reduction - CAP, 2026 -- CAP Guidelines
5. the pathologist — Leading Pathology’s Digital Evolution
6. Interpretive Diagnostic Error Reduction - CAP
7. Recommendation Statement for the Validation, Implementation, and Clinical Application of Artificial Intelligence Within a Clinical Laboratory from the Digital Pathology Association - Nathan Silberman, Anil Parwani, David S. McClintock, Giovanni Lujan, Dibson D. Gondim, Christopher Garcia, Matthew G. Hanna, Liron Pantanowitz, Jochen K. Lennerz, Timothy Showalter, Paul Gerrard, 2026
8. Definitions and General Oversight: Laboratory Developed Tests FAQs | FDA